Square Pharmaceuticals PLC. (DSE: SQURPHARMA)

SQURPHARMA Revenue

Square Pharmaceuticals PLC. had revenue of 17.23B BDT in the quarter ending March 31, 2024, with 8.44% growth. This brings the company's revenue in the last twelve months to 68.81B, up 10.95% year-over-year. In the fiscal year ending June 30, 2023, Square Pharmaceuticals PLC. had annual revenue of 62.75B with 8.94% growth.

• Revenue (ttm): 68.81B
• Revenue Growth: +10.95%
• P/S Ratio: 2.97
• Revenue / Employee: 5.50M
• Employees: 12,503
• Market Cap: 204.59B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2023	62.75B	5.15B	8.94%
Jun 30, 2022	57.60B	6.89B	13.60%
Jun 30, 2021	50.70B	4.83B	10.52%
Jun 30, 2020	45.88B	1.84B	4.19%
Jun 30, 2019	44.03B	4.38B	11.05%